BMAL1 and cutaneous melanoma: BMAL1 is physiologically downregulated during activation of NF-κB-related inflammatory responses through p65 subunit phosphorylation, but our analysis showed a positive correlation between the expression of NF-κB and BMAL1 in both primary and metastasis cutaneous melanoma.